SLC27A2 and neuroblastoma: To explore potential for targeting SLC27A2, we compared SLC27A2 mRNA expression in three NB cohorts (Lastowska, GSE13136, n = 30; Hiyama, GSE16237, n = 51; Versteeg, GSE16476, n = 88) with normal tissue cohort (Adrenal Gland, SN_ADGL, n = 13; Neural Crest, GSE14340, n = 5; Normal Various, GSE7307, n = 504 including 108 types of normal tissues; datasets generated from the same u133p2 platform and normalized by MAS5.0).